Polar Asset Management Partners Inc.
Source: SEC Form 13F · as of Mar 2026Polar Asset Management Partners Inc. holds 8 biotech & pharma companies tracked by BioSniper, totaling $86.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$86.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 725,000 | $38.2M |
| FOLDAMICUS THERAPEUTICS, INC. | 1,543,000 | $22.3M |
| DAWNDay One Biopharmaceuticals, Inc. | 630,410 | $13.5M |
| TECHBIO-TECHNE Corp | 168,100 | $8.8M |
| OMEROMEROS CORP | 200,000 | $2.1M |
| RNAAtrium Therapeutics Inc. | 70,000 | $936K |
| BKHABlack Hawk Acquisition Corporation | 39,100 | $453K |
| CMPSCOMPASS Pathways plc | 75,000 | $415K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.